Axonal dysfunction is associated with interferon-γ levels in childhood-onset systemic lupus erythematosus : a multivoxel magnetic resonance spectroscopy study
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissionsoup.com..
OBJECTIVE: Axonal/neuronal damage has been shown to be a pathological finding that precedes neuropsychiatric manifestations in SLE. The objective of this study was to determine the presence of axonal dysfunction in childhood-onset SLE patients (cSLE) and to determine clinical, immunological and treatment features associated with its occurrence.
METHODS: We included 86 consecutive cSLE patients [median age 17 (range 5-28) years] and 71 controls [median age 18 (5-28) years]. We performed proton magnetic resonance spectroscopic imaging using point resolved spectroscopy sequence over the superior-posterior region of the corpus callosum and signals from N-acetylaspartate (NAA), choline-based (CHO), creatine-containing (Cr), myo-inositol (mI), glutamate, glutamine and lactate were measured and metabolites/Cr ratios were determined. Complete clinical, laboratory and neurological evaluations were performed in all subjects. Serum IL-4, IL-5, IL-6, IL-10, IL-12, IL-17, TNF-α and INF-γ cytokine levels, antiribosomal P protein antibodies (anti-P) and S100β were measured by ELISA using commercial kits. Data were compared by non-parametric tests.
RESULTS: NAA/Cr ratios (P = 0.035) and lactate/Cr ratios (P = 0.019) were significantly decreased in cSLE patients when compared with controls. In multivariate analysis, IFN-γ levels [odds ratio (OR) = 4.1; 95% CI: 2.01, 7.9] and depressive symptoms (OR = 1.9; 95% CI: 1.1, 3.2) were associated with NAA/Cr ratio. Increased CHO/Cr was associated with the presence of cognitive impairment (OR = 3.4; 95% CI: 2.034, 5.078; P < 0.001). mI/Cr ratio correlated with cumulative glucocorticoids dosage (r = 0.361, P = 0.014).
CONCLUSION: NAA and CHO ratios may be useful as biomarkers in neuropsychiatric cSLE. Longitudinal studies are necessary to determine whether they predict structural damage.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:61 |
---|---|
Enthalten in: |
Rheumatology (Oxford, England) - 61(2022), 4 vom: 11. Apr., Seite 1529-1537 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Frittoli, Renan Bazuco [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 13.04.2022 Date Revised 16.07.2022 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/rheumatology/keab530 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328277088 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328277088 | ||
003 | DE-627 | ||
005 | 20231225202618.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/rheumatology/keab530 |2 doi | |
028 | 5 | 2 | |a pubmed24n1094.xml |
035 | |a (DE-627)NLM328277088 | ||
035 | |a (NLM)34282445 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Frittoli, Renan Bazuco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Axonal dysfunction is associated with interferon-γ levels in childhood-onset systemic lupus erythematosus |b a multivoxel magnetic resonance spectroscopy study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.04.2022 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissionsoup.com. | ||
520 | |a OBJECTIVE: Axonal/neuronal damage has been shown to be a pathological finding that precedes neuropsychiatric manifestations in SLE. The objective of this study was to determine the presence of axonal dysfunction in childhood-onset SLE patients (cSLE) and to determine clinical, immunological and treatment features associated with its occurrence | ||
520 | |a METHODS: We included 86 consecutive cSLE patients [median age 17 (range 5-28) years] and 71 controls [median age 18 (5-28) years]. We performed proton magnetic resonance spectroscopic imaging using point resolved spectroscopy sequence over the superior-posterior region of the corpus callosum and signals from N-acetylaspartate (NAA), choline-based (CHO), creatine-containing (Cr), myo-inositol (mI), glutamate, glutamine and lactate were measured and metabolites/Cr ratios were determined. Complete clinical, laboratory and neurological evaluations were performed in all subjects. Serum IL-4, IL-5, IL-6, IL-10, IL-12, IL-17, TNF-α and INF-γ cytokine levels, antiribosomal P protein antibodies (anti-P) and S100β were measured by ELISA using commercial kits. Data were compared by non-parametric tests | ||
520 | |a RESULTS: NAA/Cr ratios (P = 0.035) and lactate/Cr ratios (P = 0.019) were significantly decreased in cSLE patients when compared with controls. In multivariate analysis, IFN-γ levels [odds ratio (OR) = 4.1; 95% CI: 2.01, 7.9] and depressive symptoms (OR = 1.9; 95% CI: 1.1, 3.2) were associated with NAA/Cr ratio. Increased CHO/Cr was associated with the presence of cognitive impairment (OR = 3.4; 95% CI: 2.034, 5.078; P < 0.001). mI/Cr ratio correlated with cumulative glucocorticoids dosage (r = 0.361, P = 0.014) | ||
520 | |a CONCLUSION: NAA and CHO ratios may be useful as biomarkers in neuropsychiatric cSLE. Longitudinal studies are necessary to determine whether they predict structural damage | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a childhood-onset systemic lupus erythematosus | |
650 | 4 | |a magnetic resonance spectroscopy | |
650 | 4 | |a white matter | |
650 | 7 | |a Aspartic Acid |2 NLM | |
650 | 7 | |a 30KYC7MIAI |2 NLM | |
650 | 7 | |a Lactic Acid |2 NLM | |
650 | 7 | |a 33X04XA5AT |2 NLM | |
650 | 7 | |a Interferon-gamma |2 NLM | |
650 | 7 | |a 82115-62-6 |2 NLM | |
650 | 7 | |a Choline |2 NLM | |
650 | 7 | |a N91BDP6H0X |2 NLM | |
700 | 1 | |a Pereira, Danilo Rodrigues |e verfasserin |4 aut | |
700 | 1 | |a Lapa, Aline Tamires |e verfasserin |4 aut | |
700 | 1 | |a Postal, Mariana |e verfasserin |4 aut | |
700 | 1 | |a Sinicato, Nailu Angelica |e verfasserin |4 aut | |
700 | 1 | |a Fernandes, Paula Teixeira |e verfasserin |4 aut | |
700 | 1 | |a Cendes, Fernando |e verfasserin |4 aut | |
700 | 1 | |a Castellano, Gabriela |e verfasserin |4 aut | |
700 | 1 | |a Rittner, Leticia |e verfasserin |4 aut | |
700 | 1 | |a Marini, Roberto |e verfasserin |4 aut | |
700 | 1 | |a Niewold, Timothy B |e verfasserin |4 aut | |
700 | 1 | |a Appenzeller, Simone |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rheumatology (Oxford, England) |d 1999 |g 61(2022), 4 vom: 11. Apr., Seite 1529-1537 |w (DE-627)NLM102581908 |x 1462-0332 |7 nnns |
773 | 1 | 8 | |g volume:61 |g year:2022 |g number:4 |g day:11 |g month:04 |g pages:1529-1537 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/rheumatology/keab530 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 61 |j 2022 |e 4 |b 11 |c 04 |h 1529-1537 |